Suppr超能文献

生物基产品包涵体的观点:是祸还是福?

Perspectives of inclusion bodies for bio-based products: curse or blessing?

机构信息

Christian Doppler Laboratory for Mechanistic and Physiological Methods for Improved Bioprocesses, TU Wien, Gumpendorfer Straße, 1a, 1060, Vienna, Austria.

Research Area Biochemical Engineering, Institute of Chemical, Environmental and Bioscience Engineering, TU Wien, Gumpendorfer Straße, 1a, 1060, Vienna, Austria.

出版信息

Appl Microbiol Biotechnol. 2019 Feb;103(3):1143-1153. doi: 10.1007/s00253-018-9569-1. Epub 2018 Dec 19.

Abstract

The bacterium Escherichia coli is a major host for recombinant protein production of non-glycosylated products. Depending on the expression strategy, the recombinant protein can be located intracellularly, which often leads to protein aggregates inside of the cytoplasm, forming so the called inclusion bodies (IBs). When compared to other protein expression strategies, inclusion body formation allows high product titers and also the possibility of expressing proteins being toxic for the host. In the past years, the comprehension of inclusion bodies being only inactive protein aggregates changed, and the new term of non-classical inclusion bodies emerged. These inclusion bodies are believed to contain a reasonable amount of active protein within their structure. However, subsequent downstream processing, such as homogenisation of cells, centrifugation or solubilisation of IBs, is prone to variable process performance and is often known to result in low extraction yields. It is hypothesised that variations in IB quality attributes are responsible for those effects and that such attributes can be controlled by upstream process conditions. In this review, we address the impact of process design (process parameters) in the upstream on defined inclusion body quality attributes. The following topics are therefore addressed: (i) an overview of the range of inclusion body applications (including emerging technologies); (ii) analytical methods to determine quality attributes; and (iii) screws in process engineering to achieve the desired quality attributes for different inclusion body-based applications. Process parameters in the upstream can be used to trigger different quality attributes including protein activity, but are not exploited to a satisfying content yet. Design by quality approaches in the upstream are already considered for a multitude of existing processes. Further intensifying this approach may pave the industrial application for new IB-based products and improves IB processing, as discussed within this review.

摘要

大肠杆菌是无糖产物重组蛋白生产的主要宿主。根据表达策略的不同,重组蛋白可以位于细胞内,这往往会导致细胞质内的蛋白质聚集,形成所谓的包涵体(IBs)。与其他蛋白表达策略相比,包涵体的形成允许获得更高的产物滴度,并且还可以表达对宿主有毒的蛋白。在过去的几年中,包涵体仅仅是无活性的蛋白质聚集的这种观点发生了改变,出现了新的术语——非典型包涵体。这些包涵体被认为在其结构中含有相当数量的活性蛋白。然而,随后的下游加工,如细胞匀浆、离心或包涵体的溶解,容易受到可变的工艺性能的影响,并且通常已知会导致低提取产率。人们假设包涵体质量属性的变化是造成这些影响的原因,并且这些属性可以通过上游工艺条件来控制。在这篇综述中,我们讨论了上游工艺设计(工艺参数)对特定包涵体质量属性的影响。因此,讨论了以下主题:(i)包涵体应用(包括新兴技术)的范围概述;(ii)用于确定质量属性的分析方法;(iii)在工程学中实现不同基于包涵体的应用所需的理想质量属性的方法。上游的工艺参数可用于触发不同的质量属性,包括蛋白质活性,但尚未得到充分利用。上游的质量设计方法已经被用于许多现有的工艺中。正如本综述中所讨论的,进一步加强这种方法可能会为新型基于包涵体的产品铺平工业应用的道路,并改进包涵体的处理。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验